cGMP Clinical Trial Manufacturing

Upperton has formed a strategic partnership with Aesica Pharmaceuticals (Nottingham, UK) which enables us to offer cGMP spray drying to support clinical trials manufacture. Aesica is one of Europe’s fastest-growing API manufacturer and drug formulation with customers from the USA as well as EU and non-EU countries.

Using Aesica's experience and MHRA-approved facilities allows Upperton to offer its customers a comprehensive manufacturing capability. This will enable its customers to move into clinical development with their research projects in a timely, cost-efficient way.

 

Our cGMP capabilities include:

  • Spray drying (aqueous and solvent)
  • Further formulation/manufacturing (e.g. tableting and granulation, device filling)
  • Intermediate and finished product testing
  • QA release (by in-house Qualified Person)
  • Stability testing to ICH guidelines